Emergency appeal asks Supreme Court to restore abortion pill access

A pharmaceutical company that makes the drug mifepristone filed an emergency request with the Supreme Court on Saturday to halt a lower court’s decision to block patients from getting the abortion pill by mail.

This Video Is Trending Right Now →

Danco Laboratories asked the high court for an administrative stay on the Friday ruling from the conservative Fifth Circuit Court of Appeals in Louisiana pausing telehealth access to mifepristone. It said the ruling “injects immediate confusion and upheaval into highly time-sensitive medical decisions” and forces the company, medical providers, patients and pharmacies “to guess at what is allowed and what is not.”

“The resulting chaos for patients, providers, pharmacies, and the drug-regulatory system is a qu intessential irreparable harm that underscores the need for emergency relief from this Court,” it said, asking the justices to immediately hear arguments in the case before their summer recess.

The filing elevates abortion pill access as a potential issue in this year’s high-stakes midterm elections — putting the Trump administration in a politically fraught position. During the last midterm elections in 2022, after the Supreme Court overruled Roe v. Wade, voters resoundingly backed state ballot measures and candidates who supported abortion rights, quelling an expected Republican wave.